CCM
THC icon

Coldstream Capital Management’s Tenet Healthcare THC Stock Holding History

Coldstream Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$693K Sell
3,702
-107
-3% -$19.7K 0.01% 613
2026
Q1 		$719K Buy
3,809
+27
+0.7% +$5.69K 0.01% 567
2025
Q4 		$752K Sell
3,782
-61
-2% -$12.3K 0.01% 548
2025
Q3 		$780K Buy
3,843
+221
+6% +$39.2K 0.01% 540
2025
Q2 		$637K Buy
3,622
+130
+4% +$19.6K 0.01% 556
2025
Q1 		$470K Buy
3,492
+179
+5% +$23.6K 0.01% 632
2024
Q4 		$418K Sell
3,313
-93
-3% -$13.8K 0.01% 679
2024
Q3 		$566K Buy
3,406
+74
+2% +$11.2K 0.01% 563
2024
Q2 		$443K Buy
3,332
+39
+1% +$4.7K 0.01% 599
2024
Q1 		$346K Buy
3,293
+10
+0.3% +$899 0.01% 703
2023
Q4 		$248K Sell
3,283
-349
-10% -$22.1K 0.01% 793
2023
Q3 		$239K Sell
3,632
-18
-0.5% -$1.35K 0.01% 682
2023
Q2 		$297K Sell
3,650
-700
-16% -$49.8K 0.01% 632
2023
Q1 		$258K Buy
+4,350
New +$242K 0.01% 671
2022
Q2 		– Sell
-4,079
Closed -$351K – 847
2022
Q1 		$351K Buy
4,079
+488
+14% +$40.1K 0.01% 505
2021
Q4 		$293K Buy
+3,591
New +$262K 0.01% 626

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Coldstream Capital Management's THC Position: Q2 2026 in Review

Coldstream Capital Management reduced its Tenet Healthcare (THC) stake by 2.8% in Q2 2026, selling an estimated $19.7K and leaving 3,702 shares worth $693K. The position accounts for 0.01% of the portfolio, ranked #613.

Coldstream Capital Management first reported a position in THC in Q4 2021 and has held it in 16 quarters since. The position peaked at $780K in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Coldstream Capital Management held 3,702 shares of Tenet Healthcare worth $693K as of Q2 2026.
  • Coldstream Capital Management sold 107 Tenet Healthcare shares in Q2 2026, an estimated $19.7K.
  • Tenet Healthcare made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #613 holding.
  • Coldstream Capital Management first reported a position in Tenet Healthcare in Q4 2021 and has held it in 16 quarters since.
  • Coldstream Capital Management's Tenet Healthcare position peaked at $780K in Q3 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.